These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 7433154
1. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk]. Naruszewicz M, Nowicka G. Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154 [No Abstract] [Full Text] [Related]
2. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia]. Nowicka G, Kłosiewicz-Latoszek L. Wiad Lek; 1985 Aug 15; 38(16):1179-84. PubMed ID: 4082589 [No Abstract] [Full Text] [Related]
3. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W, Reuter W. Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
4. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia. Packard CJ, Stewart JM, Third JL, Morgan HG, Lawrie TD, Shepherd J. Biochim Biophys Acta; 1980 Apr 18; 618(1):53-62. PubMed ID: 6990991 [No Abstract] [Full Text] [Related]
5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. J Clin Endocrinol Metab; 1982 Jun 18; 54(6):1210-5. PubMed ID: 7076797 [Abstract] [Full Text] [Related]
6. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)]. Titov VN, Cherniad'eva IF, Alamdarova IN, Osipov SG. Lab Delo; 1983 Jun 18; (6):29-38. PubMed ID: 6193318 [No Abstract] [Full Text] [Related]
7. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV]. Sommariva D, Scotti L, Baroni L, Beggi P, Fasoli A. Clin Ter; 1980 Mar 31; 92(6):649-55. PubMed ID: 7460493 [No Abstract] [Full Text] [Related]
8. Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias. Ballantyne FC. Ann Clin Biochem; 1984 May 31; 21 ( Pt 3)():166-75. PubMed ID: 6383181 [No Abstract] [Full Text] [Related]
14. [Preliminary evaluation of the usefulness of determination of apolipoprotein B. cholesterol and VLDL triglyceride concentrations in the early diagnosis of type IV hyperlipoproteinemia]. Bobilewicz D, Kotlicka J, Grajnert K. Pol Tyg Lek; 1981 Mar 02; 36(9):325-6. PubMed ID: 7267451 [No Abstract] [Full Text] [Related]
19. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Am J Med; 1979 Feb 02; 66(2):303-10. PubMed ID: 218451 [No Abstract] [Full Text] [Related]
20. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia. Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R. Artery; 1979 Feb 02; 5(2):125-43. PubMed ID: 231951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]